Note

美股异动 | 生物制药公司Anchiano Therapeutics(ANCN.US)暴涨近170%,此前宣布与Chemomab达成最终合并协议

· Views 24
美股异动 | 生物制药公司Anchiano Therapeutics(ANCN.US)暴涨近170%,此前宣布与Chemomab达成最终合并协议 © Reuters. 美股异动 | 生物制药公司Anchiano Therapeutics(ANCN.US)暴涨近170%,此前宣布与Chemomab达成最终合并协议

智通财经APP获悉,12月15日美股盘初,生物制药公司Anchiano Therapeutics(ANCN.US)股价暴涨,截至北京时间22:54,该股涨近170%,报4.1美元,成交量超过2045万。

Anchiano Therapeutics此前宣布与Chemomab达成最终合并协议。根据该协议,Chemomab的股东将成为合并后公司的多数股东。拟议的合并将创建一家新上市公司,专注于推进Chemomab的主导产品CM-101。两家公司持有足够股份的股东已与各自公司签订了支持交易的股东支持协议。

Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.

FOLLOWME Trading Community Website: https://www.followme.com

If you like, reward to support.
avatar

Hot

No comment on record. Start new comment.